Literature DB >> 27668144

Lean NAFLD: An Underrecognized Outlier.

Julia Wattacheril1, Arun J Sanyal2.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is commonly diagnosed in obese or overweight individuals. However, lean individuals with NAFLD are not rare but represent one significant end of the phenotypic spectrum of NAFLD. Although initial observations between obese and lean NAFLD reveal some metabolic parallels, these associations vary widely given differences in study populations and metabolic parameters assessed. The role of body composition in risk assessment is significant and incompletely assessed during most clinical encounters. Recent multinational investigation reveals an increased mortality in lean individuals with NASH. Many aspects of lean NAFLD need further exploration including epidemiology, clinical risk assessment, histologic changes unique to lean NAFLD, genetic and pathophysiologic mechanisms predisposing at risk individuals, natural history and treatment strategies in this underrecognized population.

Entities:  

Keywords:  lean; nonalcoholic fatty liver disease (NAFLD); nonalcoholic steatohepatitis (NASH); nonobese; normal weight

Year:  2016        PMID: 27668144      PMCID: PMC5030075          DOI: 10.1007/s11901-016-0302-1

Source DB:  PubMed          Journal:  Curr Hepatol Rep        ISSN: 2195-9595


  22 in total

1.  Associations of visceral and liver fat with the metabolic syndrome across the spectrum of obesity: the AGES-Reykjavik study.

Authors:  Lauren J Kim; Michael A Nalls; Gudny Eiriksdottir; Sigurdur Sigurdsson; Lenore J Launer; Annemarie Koster; Paulo H M Chaves; Birna Jonsdottir; Melissa Garcia; Vilmundur Gudnason; Tamara B Harris
Journal:  Obesity (Silver Spring)       Date:  2010-12-23       Impact factor: 5.002

2.  Lean non-alcoholic fatty liver disease (Lean-NAFLD): a major cause of cryptogenic liver disease.

Authors:  Bertrand Vos; Christophe Moreno; Nathalie Nagy; Françoise Féry; Miriam Cnop; Pierre Vereerstraeten; Jacques Devière; Michael Adler
Journal:  Acta Gastroenterol Belg       Date:  2011-09       Impact factor: 1.316

3.  Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease.

Authors:  Kausik Das; Kshaunish Das; Partha S Mukherjee; Alip Ghosh; Sumantra Ghosh; Asit R Mridha; Tapan Dhibar; Bhaskar Bhattacharya; Dilip Bhattacharya; Byomkesh Manna; Gopal K Dhali; Amal Santra; Abhijit Chowdhury
Journal:  Hepatology       Date:  2010-05       Impact factor: 17.425

4.  Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.

Authors:  Ren-Nan Feng; Shan-Shan Du; Cheng Wang; Yan-Chuan Li; Li-Yan Liu; Fu-Chuan Guo; Chang-Hao Sun
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

5.  Lean NASH: distinctiveness and clinical implication.

Authors:  Kausik Das; Abhijit Chowdhury
Journal:  Hepatol Int       Date:  2013-10-17       Impact factor: 6.047

6.  Splanchnic lipolysis in human obesity.

Authors:  Soren Nielsen; ZengKui Guo; C Michael Johnson; Donald D Hensrud; Michael D Jensen
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

7.  Ethnic differences in hepatic steatosis: an insulin resistance paradox?

Authors:  Richard Guerrero; Gloria L Vega; Scott M Grundy; Jeffrey D Browning
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

8.  Insulin resistance and metabolic syndrome in nonobese Indian patients with non-alcoholic fatty liver disease.

Authors:  Ganesh Bhat; Chalamalasetty Sreenivasa Baba; Amaresh Pandey; Neeraj Kumari; Gourdas Choudhuri
Journal:  Trop Gastroenterol       Date:  2013 Jan-Mar

9.  Nonalcoholic fatty liver disease in lean individuals in the United States.

Authors:  Zobair M Younossi; Maria Stepanova; Francesco Negro; Shareh Hallaji; Youssef Younossi; Brian Lam; Manirath Srishord
Journal:  Medicine (Baltimore)       Date:  2012-11       Impact factor: 1.889

10.  Insulin resistance and body fat distribution in South Asian men compared to Caucasian men.

Authors:  Manisha Chandalia; Ping Lin; Thanalakshmi Seenivasan; Edward H Livingston; Peter G Snell; Scott M Grundy; Nicola Abate
Journal:  PLoS One       Date:  2007-08-29       Impact factor: 3.240

View more
  23 in total

1.  Lean Nonalcoholic Steatohepatitis and Nonalcoholic Fatty Liver Disease.

Authors:  Nadege T Gunn
Journal:  Gastroenterol Hepatol (N Y)       Date:  2021-04

2.  The metabolic profiles and body composition of lean metabolic associated fatty liver disease.

Authors:  Yu-Ming Cheng; Jia-Horng Kao; Chia-Chi Wang
Journal:  Hepatol Int       Date:  2021-02-04       Impact factor: 6.047

3.  Genetic Risk for Hepatic Fat among an Ethnically Diverse Cohort of Youth: The Exploring Perinatal Outcomes among Children Study.

Authors:  Maggie A Stanislawski; Jessica Shaw; Elizabeth Litkowski; Ethan M Lange; Wei Perng; Dana Dabelea; Leslie A Lange
Journal:  J Pediatr       Date:  2020-03-04       Impact factor: 4.406

Review 4.  Non-alcoholic fatty liver disease (NAFLD) in non-obese individuals.

Authors:  Meaghan Phipps; Julia Wattacheril
Journal:  Frontline Gastroenterol       Date:  2019-12-13

5.  Whole-Exome Sequencing Identifies a Variant in Phosphatidylethanolamine N-Methyltransferase Gene to be Associated With Lean-Nonalcoholic Fatty Liver Disease.

Authors:  Govardhan Bale; Ravikanth V Vishnubhotla; Sasikala Mitnala; Mithun Sharma; Rao N Padaki; Smita C Pawar; Reddy N Duvvur
Journal:  J Clin Exp Hepatol       Date:  2019-02-11

6.  Serum magnesium concentration is independently associated with non-alcoholic fatty liver and non-alcoholic steatohepatitis.

Authors:  Ahad Eshraghian; Saman Nikeghbalian; Bita Geramizadeh; Seyed Ali Malek-Hosseini
Journal:  United European Gastroenterol J       Date:  2017-04-25       Impact factor: 4.623

Review 7.  Influence of dietary macronutrients on liver fat accumulation and metabolism.

Authors:  Siôn A Parry; Leanne Hodson
Journal:  J Investig Med       Date:  2017-09-24       Impact factor: 2.895

8.  Can Diet Help Non-Obese Individuals with Non-Alcoholic Fatty Liver Disease (NAFLD)?

Authors:  Hamid A Merchant
Journal:  J Clin Med       Date:  2017-09-19       Impact factor: 4.241

Review 9.  Nonalcoholic fatty liver disease: Evolving paradigms.

Authors:  Amedeo Lonardo; Fabio Nascimbeni; Mauro Maurantonio; Alessandra Marrazzo; Luca Rinaldi; Luigi Elio Adinolfi
Journal:  World J Gastroenterol       Date:  2017-09-28       Impact factor: 5.742

Review 10.  Lean NAFLD: an underrecognized and challenging disorder in medicine.

Authors:  Sheila Maier; Amanda Wieland; Melanie Cree-Green; Kristen Nadeau; Shelby Sullivan; Miguel A Lanaspa; Richard J Johnson; Thomas Jensen
Journal:  Rev Endocr Metab Disord       Date:  2021-01-03       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.